AmeriServ (ASRV) Director Reports 549-Share Dividend Reinvestment
Rhea-AI Filing Summary
Daniel A. Onorato, a director of AmeriServ Financial, reported acquiring 549 shares of AmeriServ Financial Inc. (ASRV) on 08/18/2025 through dividend reinvestment at an effective per-share price of $3.0109. After the transaction the reporting person beneficially owned 56,701 shares, held directly. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 08/27/2025. The filing discloses a routine, non-derivative purchase tied to dividend reinvestment rather than an open-market trade or stock grant.
Positive
- Ownership increased by 549 shares through dividend reinvestment, raising beneficial ownership to 56,701 shares
- Filing compliance: Form 4 was completed and signed by an attorney-in-fact, indicating procedural adherence
Negative
- None.
Insights
TL;DR: Small, routine ownership increase via dividend reinvestment; limited market impact.
The Form 4 shows a non-derivative acquisition of 549 shares at $3.0109 per share through a dividend reinvestment plan, bringing the holder to 56,701 shares. This is an administratively driven increase rather than a discretionary purchase and does not indicate a change in compensation or a large-scale insider buying program. For investors, the filing documents insider ownership continuity but is unlikely to move valuation or signal material new information.
TL;DR: Compliance filing documents routine dividend reinvestment; governance impact is minimal.
The disclosure identifies the reporting person as a director and reports shares acquired via dividend reinvestment, a common mechanism that maintains or modestly increases insider ownership without active trading. The Form 4 was timely and signed via attorney-in-fact, meeting procedural requirements. There are no derivative transactions, no changes in officer status, and no indications of material corporate actions in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 549 | $3.0109 | $2K |
Footnotes (1)
- [object Object]
FAQ
What transaction did Daniel A. Onorato report on Form 4 for ASRV?
Was the transaction a market purchase, option exercise, or dividend reinvestment?
When was the Form 4 signed and filed?